e-learning
resources
London 2016
Monday, 05.09.2016
Microbiological issues and translational research in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring of pneumocystis jirovecii pneumonia by specialized pro-resolving mediators
Marc Dubourdeau (Toulouse, France), Marc Dubourdeau, Vincent Baillif, Gerald Chene, Charlotte Guigne, Estelle Wanecq, Emeline Van Goethem, Marine Le Bouar, Antoine Berry, Xavier Iriart
Source:
International Congress 2016 – Microbiological issues and translational research in respiratory infections
Session:
Microbiological issues and translational research in respiratory infections
Session type:
Thematic Poster
Number:
2627
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marc Dubourdeau (Toulouse, France), Marc Dubourdeau, Vincent Baillif, Gerald Chene, Charlotte Guigne, Estelle Wanecq, Emeline Van Goethem, Marine Le Bouar, Antoine Berry, Xavier Iriart. Monitoring of pneumocystis jirovecii pneumonia by specialized pro-resolving mediators. Eur Respir J 2016; 48: Suppl. 60, 2627
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Pneumocystis
pneumonia in the non-HIV population
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Prognosis of
pneumocystis jirovecii
pneumonia in non-HIV patients
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Biomarkers for oxidative stress in patients with community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Cytokines and local inflammation in pneumonia
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005
Pulmonary embolism or Pneumocystis jiroveci pneumonia?
Source: ISSN=ISSN 1810-6838, ISBN=, page=83
Year: 2006
Clinical and radiological features of pneumocystis pneumonia in immunocompromised non-HIV patients
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Role of pneumocystis jiroveci in interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
Evaluation of β-D-glucan, LD and KL-6 in the diagnosis and monitoring of
Pneumocystis carinii
pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 336s
Year: 2003
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Compared efficacies of lung delivery using two nebulizers in the prophylaxis against pneumocystis carinii pneumonia
Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections
Year: 2016
Biomarkers in community-acquired pneumonia: still searching for the one
Source: Eur Respir J, 53 (2) 1802469; 10.1183/13993003.02469-2018
Year: 2019
Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Outbreak of
pneumocystis jiroveci
pneumonia among renal transplant patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
The results of immunotherapy of community acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Lymphopoenia and pneumocystis jiroveci (PCP) prophylaxis experience in non-specific interstitial pneumonitis (NSIP)
Source: International Congress 2014 – ILDs 2
Year: 2014
Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept